Global Functional Dyspepsia Drug Market Size, Share, Trends and Forecast 2022-2030

Description

Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.
Industry Insights

Due to the COVID-19 pandemic, the global Functional Dyspepsia Drug market size is estimated to be worth US$ 5948.9 million in 2021 and is forecast to a readjusted size of US$ 7234.2 million by 2028 with a CAGR of 2.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Functional Dyspepsia Drug market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Functional Dyspepsia Drug landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.

This report focuses on Functional Dyspepsia Drug volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Functional Dyspepsia Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Functional Dyspepsia Drug market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Prokinetic Drugs

Gastric Antisecretory Drugs

Others

Segment by Application

Hospitals

Drugstores

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Bayer

Sumitomo

Cadila Pharmaceuticals

Teva

Johnson & Johnson

Pfizer

Sanofi

AstraZeneca

Jiangsu Aosaikang Pharma

Eisai

Kyowa Kirin Pharmaceuticals

Hanmi Pharm

TABLE OF CONTENT

1 Functional Dyspepsia Drug Market Overview
1.1 Product Overview and Scope of Functional Dyspepsia Drug

1.2 Functional Dyspepsia Drug Segment by Type

1.2.1 Global Functional Dyspepsia Drug Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Prokinetic Drugs

1.2.3 Gastric Antisecretory Drugs

1.2.4 Others

1.3 Functional Dyspepsia Drug Segment by Application

1.3.1 Global Functional Dyspepsia Drug Sales Comparison by Application: (2022-2028)

1.3.2 Hospitals

1.3.3 Drugstores

1.4 Global Functional Dyspepsia Drug Market Size Estimates and Forecasts

1.4.1 Global Functional Dyspepsia Drug Revenue 2017-2028

1.4.2 Global Functional Dyspepsia Drug Sales 2017-2028

1.4.3 Functional Dyspepsia Drug Market Size by Region: 2017 Versus 2021 Versus 2028

2 Functional Dyspepsia Drug Market Competition by Manufacturers

2.1 Global Functional Dyspepsia Drug Sales Market Share by Manufacturers (2017-2022)

2.2 Global Functional Dyspepsia Drug Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Functional Dyspepsia Drug Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Functional Dyspepsia Drug Manufacturing Sites, Area Served, Product Type

2.5 Functional Dyspepsia Drug Market Competitive Situation and Trends

2.5.1 Functional Dyspepsia Drug Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Functional Dyspepsia Drug Players Market Share by Revenue

2.5.3 Global Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Functional Dyspepsia Drug Retrospective Market Scenario by Region

3.1 Global Functional Dyspepsia Drug Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Functional Dyspepsia Drug Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Functional Dyspepsia Drug Market Facts & Figures by Country

3.3.1 North America Functional Dyspepsia Drug Sales by Country

3.3.2 North America Functional Dyspepsia Drug Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Functional Dyspepsia Drug Market Facts & Figures by Country

3.4.1 Europe Functional Dyspepsia Drug Sales by Country

3.4.2 Europe Functional Dyspepsia Drug Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Functional Dyspepsia Drug Market Facts & Figures by Region

3.5.1 Asia Pacific Functional Dyspepsia Drug Sales by Region

3.5.2 Asia Pacific Functional Dyspepsia Drug Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Functional Dyspepsia Drug Market Facts & Figures by Country

3.6.1 Latin America Functional Dyspepsia Drug Sales by Country

3.6.2 Latin America Functional Dyspepsia Drug Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Functional Dyspepsia Drug Market Facts & Figures by Country

3.7.1 Middle East and Africa Functional Dyspepsia Drug Sales by Country

3.7.2 Middle East and Africa Functional Dyspepsia Drug Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Functional Dyspepsia Drug Historic Market Analysis by Type

4.1 Global Functional Dyspepsia Drug Sales Market Share by Type (2017-2022)

4.2 Global Functional Dyspepsia Drug Revenue Market Share by Type (2017-2022)

4.3 Global Functional Dyspepsia Drug Price by Type (2017-2022)

5 Global Functional Dyspepsia Drug Historic Market Analysis by Application

5.1 Global Functional Dyspepsia Drug Sales Market Share by Application (2017-2022)

5.2 Global Functional Dyspepsia Drug Revenue Market Share by Application (2017-2022)

5.3 Global Functional Dyspepsia Drug Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Bayer

6.1.1 Bayer Corporation Information

6.1.2 Bayer Description and Business Overview

6.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Bayer Functional Dyspepsia Drug Product Portfolio

6.1.5 Bayer Recent Developments/Updates

6.2 Sumitomo

6.2.1 Sumitomo Corporation Information

6.2.2 Sumitomo Description and Business Overview

6.2.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Sumitomo Functional Dyspepsia Drug Product Portfolio

6.2.5 Sumitomo Recent Developments/Updates

6.3 Cadila Pharmaceuticals

6.3.1 Cadila Pharmaceuticals Corporation Information

6.3.2 Cadila Pharmaceuticals Description and Business Overview

6.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Portfolio

6.3.5 Cadila Pharmaceuticals Recent Developments/Updates

6.4 Teva

6.4.1 Teva Corporation Information

6.4.2 Teva Description and Business Overview

6.4.3 Teva Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Teva Functional Dyspepsia Drug Product Portfolio

6.4.5 Teva Recent Developments/Updates

6.5 Johnson & Johnson

6.5.1 Johnson & Johnson Corporation Information

6.5.2 Johnson & Johnson Description and Business Overview

6.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Johnson & Johnson Functional Dyspepsia Drug Product Portfolio

6.5.5 Johnson & Johnson Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Pfizer Functional Dyspepsia Drug Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

6.7 Sanofi

6.6.1 Sanofi Corporation Information

6.6.2 Sanofi Description and Business Overview

6.6.3 Sanofi Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Sanofi Functional Dyspepsia Drug Product Portfolio

6.7.5 Sanofi Recent Developments/Updates

6.8 AstraZeneca

6.8.1 AstraZeneca Corporation Information

6.8.2 AstraZeneca Description and Business Overview

6.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)

6.8.4 AstraZeneca Functional Dyspepsia Drug Product Portfolio

6.8.5 AstraZeneca Recent Developments/Updates

6.9 Jiangsu Aosaikang Pharma

6.9.1 Jiangsu Aosaikang Pharma Corporation Information

6.9.2 Jiangsu Aosaikang Pharma Description and Business Overview

6.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Portfolio

6.9.5 Jiangsu Aosaikang Pharma Recent Developments/Updates

6.10 Eisai

6.10.1 Eisai Corporation Information

6.10.2 Eisai Description and Business Overview

6.10.3 Eisai Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Eisai Functional Dyspepsia Drug Product Portfolio

6.10.5 Eisai Recent Developments/Updates

6.11 Kyowa Kirin Pharmaceuticals

6.11.1 Kyowa Kirin Pharmaceuticals Corporation Information

6.11.2 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Description and Business Overview

6.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Portfolio

6.11.5 Kyowa Kirin Pharmaceuticals Recent Developments/Updates

6.12 Hanmi Pharm

6.12.1 Hanmi Pharm Corporation Information

6.12.2 Hanmi Pharm Functional Dyspepsia Drug Description and Business Overview

6.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Hanmi Pharm Functional Dyspepsia Drug Product Portfolio

6.12.5 Hanmi Pharm Recent Developments/Updates

7 Functional Dyspepsia Drug Manufacturing Cost Analysis

7.1 Functional Dyspepsia Drug Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Functional Dyspepsia Drug

7.4 Functional Dyspepsia Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Functional Dyspepsia Drug Distributors List

8.3 Functional Dyspepsia Drug Customers

9 Functional Dyspepsia Drug Market Dynamics

9.1 Functional Dyspepsia Drug Industry Trends

9.2 Functional Dyspepsia Drug Market Drivers

9.3 Functional Dyspepsia Drug Market Challenges

9.4 Functional Dyspepsia Drug Market Restraints

10 Global Market Forecast

10.1 Functional Dyspepsia Drug Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Functional Dyspepsia Drug by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Functional Dyspepsia Drug by Type (2023-2028)

10.2 Functional Dyspepsia Drug Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Functional Dyspepsia Drug by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Functional Dyspepsia Drug by Application (2023-2028)

10.3 Functional Dyspepsia Drug Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Functional Dyspepsia Drug by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Functional Dyspepsia Drug by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample